Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Trobalt / Potiga – Treatment for Partial-Onset Seizure

Trobalt (ezogabine/retigabine) is indicated for the treatment of partial-onset epileptic seizures in patients aged more than 18 years old. Canada-based Valeant Pharmaceuticals and GlaxoSmithKline are developing the drug jointly.



Go Top